SEC Form 4 · accession 0001574774-18-000027
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather C Getz
Officer — Executive VP & CFO
Period of report
Apr 26, 2018
Accepted (ET)
Apr 27, 2018 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 26, 2018 | M | 40,000 | $17.44 | A | 84,156 | D | |
| Common Stock | Apr 26, 2018 | M | 10,000 | $6.95 | A | 94,156 | D | |
| Common Stock | Apr 26, 2018 | M | 10,000 | $6.43 | A | 104,156 | D | |
| Common Stock | Apr 26, 2018 | M | 5,570 | $8.79 | A | 109,726 | D | |
| Common StockF2 | Apr 26, 2018 | S | 65,570 | $38.03 | D | 44,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $17.44 | Apr 26, 2018 | M | 40,000 | D | Dec 15, 2009 | May 11, 2019 | Common Stock | 40,000 | 0 | D |
| Stock Options (Right to Buy)F3 | $6.95 | Apr 26, 2018 | M | 10,000 | D | — | Aug 12, 2019 | Common Stock | 10,000 | 0 | D |
| Stock Options (Right to Buy)F4 | $6.43 | Apr 26, 2018 | M | 10,000 | D | — | Jan 22, 2020 | Common Stock | 10,000 | 0 | D |
| Stock Options (Right to Buy)F5 | $8.79 | Apr 26, 2018 | M | 5,570 | D | — | May 10, 2020 | Common Stock | 5,570 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.00 to $38.65, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3The stock options vested in four equal annual installments which began on August 12, 2010. The options were fully exercisable as of August 12, 2013.
- F4The stock options vested in four equal annual installments which began on January 22, 2011. The options were fully exercisable as of January 22, 2014.
- F5The stock options vested in four equal annual installments which began on May 10, 2011. The options were fully exercisable as of May 10, 2014.